{"title":"Medicines for Infections and Skin Lesions","description":"\u003cp\u003eMedicines and devices for damaged skin: repairing and healing creams for wounds and sores, impregnated gauzes and dressings, keratolytic colloids and plasters for warts and calluses, acne treatments. Fast shipping in 24\/48 hours.\u003c\/p\u003e","products":[{"product_id":"duofilm-16-7-15-collodio-15ml","title":"Duofilm 16.7% + 15% collodion 15ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDUOFILM is indicated for the topical treatment of warts, corns and calluses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine is contraindicated in patients with a previous hypersensitivity reaction to the active substances or to any of the excipients listed in paragraph 6.1. Do not use on open wounds, irritated or red skin, or any infected area. DUOFILM should not be applied to the face, anogenital area and large areas. The product should not be applied to moles, birthmarks, seborrheic warts, warts, facial or mucous membrane warts, or hairy warts surrounded by red or unusually colored edges.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. In this case it is necessary to interrupt treatment and institute appropriate therapy. Apply DUOFILM only on warts without overflowing onto the surrounding healthy skin. The medicine may cause eye irritation. Avoid contact with eyes and other mucous membranes. If the product accidentally comes into contact with mucous membranes or eyes, rinse immediately and abundantly with water, remove the collodion film that forms and continue rinsing with water for at least a quarter of an hour. Avoid application on healthy skin (see Side effects). The medicine may cause skin irritation. If unexpected skin irritation develops, treatment should be discontinued. Consider alternative treatment if warts cover a large area of ​​the body (more than 5 cm²) due to the potential toxicity of salicylates. The medicine is not recommended in diabetic patients or patients with circulatory problems or peripheral neuropathy, unless under the supervision of a doctor. Taking oral salicylates during or immediately after a viral illness has been associated with Reye's syndrome and consequently there is a theoretical risk also with topical salicylates. Therefore, the product should not be used in children or adolescents during or immediately after chickenpox, influenza or other viral infections. Salicylates have been reported to be excreted in breast milk (see Fertility, pregnancy and lactation). Patients should be advised not to inhale vapours. Accidental ingestion of keratolytics containing salicylic acid and lactic acid at high concentrations can have serious, sometimes fatal, consequences. The product must not be used to prevent the formation of warts. Do not ingest. Keep out of the sight and reach of children. This medicinal product contains 2228 mg of alcohol (ethanol) in each unit volume which is equivalent to 158 mg\/g. May cause burning sensation on damaged skin.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSalicylic acid and lactic acid topical solution may increase the absorption of other topical medications. Therefore the concomitant use of salicylic acid and lactic acid solution and other topical medicines on the treated area should be avoided. Since the systemic absorption of topical solutions of salicylic acid and lactic acid is low, interaction with systemically administered medicinal products is not expected.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following convention is used to classify the frequency of an adverse reaction and is based on the CIOMS guidelines: • very common (\u003e 1\/10), • common (\u003e 1\/100 to \u003c 1\/10), • uncommon (\u003e1\/1,000 to \u003c 1\/100), • rare (\u003e 1\/10,000 to \u003c 1\/1,000) and • very rare (\u003c 1\/10,000), • not known (frequency cannot be estimated from the available data). Data from clinical studies:\u003c\/p\u003e\n\u003cp\u003eImmune system disorders\u003c\/p\u003e\n\u003cp\u003eMunicipality | Skin rash\u003c\/p\u003e\n\u003cp\u003ePathologies of the skin and subcutaneous tissue\u003c\/p\u003e\n\u003cp\u003eVery common | Application site reaction, pruritus, burning sensation, erythema, scaling, dryness\u003c\/p\u003e\n\u003cp\u003eMunicipality: | Skin hypertrophy\u003c\/p\u003e\n\u003cp\u003ePost marketing data\u003c\/p\u003e\n\u003cp\u003eImmune system disorders\u003c\/p\u003e\n\u003cp\u003eRare | Application site hypersensitivity reaction including inflammation\u003c\/p\u003e\n\u003cp\u003ePathologies of the skin and subcutaneous tissue\u003c\/p\u003e\n\u003cp\u003eRare | Pain at the application site and irritation, discolouration of the skin at the application site\/discolouration of the skin. Exposure of healthy skin may lead to skin exfoliation and blistering (see Special warnings and precautions for use). Allergic dermatitis\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions \u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e","brand":"Eg","offers":[{"title":"Default Title","offer_id":51131289010503,"sku":"034522019","price":15.35,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/eg-spa-duofilm-16-7-15-collodio-15ml-farmacia-dottor-tili-1213792222.jpg?v=1767134130"},{"product_id":"streptosil-con-neomicina-99-5-0-5-polvere-cutanea-10g","title":"Streptosil with neomycin 99.5% + 0.5% skin powder 10g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSuperficial skin infections (folliculitis, furunculosis, small burns and infected wounds).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSTREPTOSIL with NEOMICIN is contraindicated in patients with: - Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. - Infections of the ear canal in case of perforation of the tympanic membrane.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSTREPTOSIL with NEOMICIN is not for ophthalmic use; it is indicated for external use only. The application of STREPTOSIL with NEOMICIN on extensively and deeply damaged skin, such as in skin infections secondary to extensive burns and trophic ulcers, could favor the systemic absorption of its active ingredients, exposing patients to serious secondary effects, such as nephrotoxicity and ototoxicity. The medicine must not be used in ear canal infections in case of perforation of the eardrum since in these cases the topical use of neomycin can cause deafness (see section 4.3). As with other aminoglycosides, the simultaneous and\/or sequential systemic or topical administration of other nephrotoxic drugs should be avoided. \u003ci\u003eDuration of treatment\u003c\/i\u003e The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. As with other antibiotics, prolonged use of neomycin can lead to the development of resistant microorganisms, including fungi. If this occurs it is necessary to discontinue treatment and institute appropriate therapy. After a short period of treatment without appreciable results, or in case of worsening of the patient's condition, it is necessary to consider suspending treatment. \u003ci\u003e Pediatric population\u003c\/i\u003e In early childhood the product should be administered in cases of actual need, under the direct supervision of the doctor. The application of neomycin on large areas of the skin and for prolonged periods can lead to systemic absorption; this eventuality occurs more easily when occlusive bandage is used, in particular in newborns, since the diaper can act as an occlusive bandage.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTopical neomycin has demonstrated cross-sensitivity with other aminoglycosides; co-administration of another aminoglycoside, especially systemically, is not recommended due to potential ototoxic and nephrotoxic effects. Topical application of sulfathiazole may result in sensitization and preclude subsequent systemic use of sulfonamides.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFollowing the use of STREPTOSIL with NEOMICIN, the side effects indicated below may occur. The frequency of these side effects is not known. \u003cu\u003eInfections and infestations\u003c\/u\u003e Bacterial and fungal superinfections. \u003cu\u003eImmune system disorders\u003c\/u\u003e Hypersensitivity reactions \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e Itching. \u003cu\u003eSystemic pathologies and conditions relating to the administration site\u003c\/u\u003e Swelling, redness. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa.\u003c\/p\u003e","brand":"Cheplapharm","offers":[{"title":"Default Title","offer_id":51131295760711,"sku":"023589031","price":10.23,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/cheplapharm-arzneimittel-gmbh-streptosil-con-neomicina-99-5-0-5-polvere-cutanea-10g-farmacia-dottor-tili-1213792203.jpg?v=1767134508"},{"product_id":"trofodermin-5-5-30-ml-spray-cutaneo-soluzione","title":"Trofodermin 5% + 5% 30 ml cutaneous spray solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAbrasions and erosions; ulcerative skin lesions (variceal ulcers, bedsores, traumatic ulcers); nipple fissures, anal fissures; burns; infected wounds; healing delays; radiodermatitis; dystrophic skin conditions (dryness, cracking, flaking).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eContinuous use of Trofodermin should be avoided. Due to the potential risk of ototoxicity and nephrotoxicity of neomycin, prolonged use of the product on large damaged surfaces that could allow the absorption of neomycin is not recommended. \u003cu\u003ePediatric population\u003c\/u\u003e Continuous use of Trofodermin should be avoided; especially in early childhood. \u003ci\u003eTrofodermin 5 mg\/ml + 5 mg\/ml cutaneous spray, suspension\u003c\/i\u003e As regards the spray, it is recommended to shake before use, not to spray on a flame or incandescent body, not to turn upside down during dispensing, not to inhale or spray into the eyes. \u003ci\u003eTrofodermin 500 mg\/100 g + 500 mg\/100 g cream\u003c\/i\u003e contains: – lanolin: can cause local skin reactions (e.g. contact dermatitis) – nipasept (methyl para-hydroxybenzoate, ethyl para-hydroxybenzoate and propyl para-hydroxybenzoate): can cause allergic reactions (even delayed).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe combined use of Trofodermin with topical preparations containing other aminoglycoside antibiotics may increase the risk of sensitization or enhance any secondary effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. Furthermore, prolonged application for several weeks on large areas of damaged tissue could give rise to the appearance of systemic effects, such as hypertrichosis due to massive absorption of clostebol. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e","brand":"Sit Laboratorio Farmaceutico","offers":[{"title":"Default Title","offer_id":51730202591559,"sku":"020942049","price":12.54,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/sit-laboratorio-farmac-srl-trofodermin-5-5-30-ml-spray-cutaneo-soluzione-farmacia-dottor-tili-1213791406.jpg?v=1767138167"},{"product_id":"streptosil-neomicina-2-0-5-20-g-unguento","title":"Streptosyl neomycin 2% + 0.5% 20 g ointment","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSuperficial skin infections (folliculitis, furunculosis, small burns and infected wounds).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSTREPTOSIL with NEOMICIN is contraindicated in patients with: - Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. - Infections of the ear canal in case of perforation of the tympanic membrane.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSTREPTOSIL with NEOMICIN is not for ophthalmic use; it is indicated for external use only. The application of STREPTOSIL with NEOMICIN on extensively and deeply damaged skin, such as in skin infections secondary to extensive burns and trophic ulcers, could favor the systemic absorption of its active ingredients, exposing patients to serious secondary effects, such as nephrotoxicity and ototoxicity. The medicine must not be used in ear canal infections in case of perforation of the eardrum since in these cases the topical use of neomycin can cause deafness (see section 4.3). As with other aminoglycosides, the simultaneous and\/or sequential systemic or topical administration of other nephrotoxic drugs should be avoided. \u003ci\u003eDuration of treatment\u003c\/i\u003e The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. As with other antibiotics, prolonged use of neomycin can lead to the development of resistant microorganisms, including fungi. If this occurs it is necessary to discontinue treatment and institute appropriate therapy. After a short period of treatment without appreciable results, or in case of worsening of the patient's condition, it is necessary to consider suspending treatment. \u003ci\u003e Pediatric population\u003c\/i\u003e In early childhood the product should be administered in cases of actual need, under the direct supervision of the doctor. The application of neomycin on large areas of the skin and for prolonged periods can lead to systemic absorption; this eventuality occurs more easily when occlusive bandage is used, in particular in newborns, since the diaper can act as an occlusive bandage.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTopical neomycin has demonstrated cross-sensitivity with other aminoglycosides; co-administration of another aminoglycoside, especially systemically, is not recommended due to potential ototoxic and nephrotoxic effects. Topical application of sulfathiazole may result in sensitization and preclude subsequent systemic use of sulfonamides.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFollowing the use of STREPTOSIL with NEOMICIN, the side effects indicated below may occur. The frequency of these side effects is not known. \u003cu\u003eInfections and infestations\u003c\/u\u003e Bacterial and fungal superinfections. \u003cu\u003eImmune system disorders\u003c\/u\u003e Hypersensitivity reactions \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e Itching. \u003cu\u003eSystemic pathologies and conditions relating to the administration site\u003c\/u\u003e Swelling, redness. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa.\u003c\/p\u003e","brand":"Cheplapharm","offers":[{"title":"Default Title","offer_id":51730202853703,"sku":"023589043","price":11.01,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/cheplapharm-arzneimittel-gmbh-streptosil-neomicina-2-0-5-20-g-unguento-farmacia-dottor-tili-1213791441.jpg?v=1767138250"},{"product_id":"metronidazolo-same-1-30-g-gel","title":"Metronidazole Same 1% 30g gel","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMETRONIDAZOLE SAME is indicated for topical application in the treatment of inflammatory papules, pustules and erythema of rosacea.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. Contraindicated during pregnancy and breastfeeding (see p.4.6).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHowever, due to the minimal absorption of Metronidazole applied locally and, consequently, the negligible plasma concentrations, the side effects reported following oral administration of the drug were not recorded following topical application. Avoid contact with eyes and mucous membranes; Metronidazole applied to the face has been reported to cause tearing. In case of contact with eyes, the gel must be carefully removed with water. The patient should be informed that if irritation occurs, he or she should use Metronidazole Same less frequently or temporarily suspend therapy and inform the doctor. Avoid exposure to ultraviolet light (sun, UV lamps, tanning equipment) during therapy with Metronidazole Same. Since the drug is a nitroimidazole derivative it must be used with caution in patients presenting with blood dyscrasias or with anamnestic data relating to them. The product must be used according to the instructions provided by the treating doctor. Do not exceed the recommended doses. The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. There are no adequate clinical data on the efficacy and safety of Metronidazole Same in children, therefore Metronidazole Same should not be used in children. Do not ingest. Keep out of reach of children. This medicine contains methyl parahydroxybenzoate, which may cause allergic reactions (possibly delayed).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn consideration of the low blood levels resulting from the topical application of Metronidazole, interactions with other drugs are unlikely. However, it must be remembered that disulfiram-like reactions have been reported in a small number of patients taking metronidazole and alcohol at the same time and in the case of treatment of patients undergoing anticoagulant therapy at the same time, it must be kept in mind that Metronidazole, following oral administration, determines an enhancement of the anticoagulant effects of coumarins and warfarin which manifests itself by inducing a prolongation of the prothrombin time. The effect of topical metronidazole on prothrombin time is not known.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFollowing the use of topical Metronidazole, the following side effects have been reported: Skin and subcutaneous tissue disorders: contact dermatitis, dry skin, erythema, itching, rash, skin discomfort (burning and stinging sensation), skin irritation, transient redness and worsening of rosacea. Eye disorders: tearing. None of these side effects occurred in more than 2% of treated patients. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e","brand":"Savoma","offers":[{"title":"Default Title","offer_id":51730203312455,"sku":"028523013","price":15.68,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/savoma-metronidazolo-same-1-30-g-gel-farmacia-dottor-tili-1258975901.jpg?v=1790944400"},{"product_id":"rozex-0-75-50-g-crema","title":"Rozex 0.75% 50g cream","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRozex 0.75% cream is indicated in the topical treatment of rosacea in its erythematous and papulopustular manifestations.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid contact with eyes and mucous membranes. During therapy with metronidazole, avoid exposure to UV rays (exposure to sun rays, solariums and sun lamps). Metronidazole converts into an inactive metabolite as a result of UV exposure, therefore its effectiveness decreases significantly. No side effects of phototoxicity have been reported in clinical studies in relation to metronidazole. If a reaction due to local irritation should occur, it is advisable to reduce the number of daily applications of the drug or to suspend administration according to the doctor's opinion. Metronidazole is a nitroimidazole compound and should therefore be used with caution in patients with blood dyscrasia. Avoid unnecessary and prolonged use of this medicine. Metronidazole has been shown to be carcinogenic in some animal species. There are no data demonstrating its carcinogenic effect in humans. \u003cb\u003eImportant information about some excipients.\u003c\/b\u003e \u003cb\u003eRozex 0.75% cream contains: cetylstearyl alcohol which may cause localized skin reactions (e.g. contact dermatitis). This medicinal product also contains 22 mg of benzyl alcohol (E1519) per gram, equivalent to 2.2% w\/w, which may cause allergic reactions and mild local irritation.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConsidering the poor systemic absorption of Rozex 0.75% cream applied topically, negative interactions with other drugs are quantitatively irrelevant. Metronidazole administered orally can lead to an enhancement of the effects of anticoagulant drugs. An increase in prothrombin time has been observed after concomitant administration of oral metronidazole and an oral coumarin-type anticoagulant (Warfarin). The effect of topical metronidazole on prothrombin time is unknown. Furthermore, in a small number of patients taking oral metronidazole and alcohol at the same time, a reaction similar to that which occurs with Disulfiram occurred.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOnly mild local reactions occurred during topical use of Rozex 0.75% cream. The following spontaneous adverse reactions have been reported and these are ranked by frequency within system organ classes, according to the following convention: very common (≥ 1\/10) common (≥ 1\/100, \u003c 1\/10) uncommon (≥ 1\/1,000, \u003c 1\/100) rare (≥ 1\/10,000, \u003c 1\/1,000) very rare (\u003c 1\/10,000) not known (frequency cannot be estimated from the available data) \u003cu\u003ePathology of the skin and subcutaneous tissue:\u003c\/u\u003e Common: dry skin, erythema, pruritus, skin discomfort (burning, skin pain, stinging), skin irritation, worsening of rosacea. Not known: contact dermatitis, skin exfoliation, facial swelling. \u003cu\u003eNervous system disorders:\u003c\/u\u003e Uncommon: hypoesthesia, paraesthesia, dysgeusia (metallic taste).\u003cu\u003eGastrointestinal disorders:\u003c\/u\u003e Uncommon: nausea. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e","brand":"Galderma","offers":[{"title":"Default Title","offer_id":51730203869511,"sku":"028809085","price":37.91,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/galderma-italia-spa-rozex-0-75-50-g-crema-farmacia-dottor-tili-1213791418.jpg?v=1767138750"},{"product_id":"fitostimoline-15-32-g-crema-garze-impregnate","title":"Fitostimoline 15% 32 g cream + impregnated gauze","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eFITOSTIMOLINES 15% Cream and FITOSTIMOLINES 15% Impregnated gauzes\u003c\/b\u003e: treatment of ulcers and bedsores\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance to any of the excipients.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use, especially if prolonged, of all products for topical use can give rise to sensitization phenomena. If this occurs, treatment should be suspended and appropriate therapy instituted, if necessary. The same applies in the case of the development of insensitive germs. \u003cb\u003eImportant information about some excipients\u003c\/b\u003e \u003cb\u003ePhytostimolines 15% Cream \u003c\/b\u003econtains cetyl and stearyl alcohol: they may cause localized skin reactions (e.g. contact dermatitis).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known interactions or incompatibilities.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo side clinical manifestations or unwanted secondary effects have been reported.\u003c\/p\u003e","brand":"Damor","offers":[{"title":"Default Title","offer_id":51730204098887,"sku":"009115027","price":17.1,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/farmaceutici-damor-spa-fitostimoline-15-32-g-crema-garze-impregnate-farmacia-dottor-tili-1213791412.jpg?v=1767138869"},{"product_id":"verunec-15-g-15-g-100-g-10-g-collodio","title":"Verunec 15 g + 15 g\/100 g 10 g collodion","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment of vulgar, plantar and mosaic warts; calluses and calluses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients. VERUNEC should not be used by diabetics or patients with impaired blood circulation. VERUNEC, like all products with a high salicylic acid content, should not be applied to the face and anogenital area.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product must not be applied on: seborrheic warts, facial warts, warts, skin nevi. Avoid contact with eyes and mucous membranes. If the product is spilled into the eyes or on the mucous membranes, wash with water, remove the precipitated collodion and wash again with water for 15 minutes. Avoid application on normal skin surrounding the callus. The product is for external use only. The use, especially prolonged, of products for topical use can give rise to sensitization phenomena. In this case, stop treatment and consult your doctor to institute suitable therapy. Do not ingest. In case of accidental ingestion of the product, consult a doctor immediately. The product must not be used to prevent the formation of warts. Keep out of reach of children. Do not use for prolonged treatments; after a short period of treatment without appreciable results, consult your doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid the simultaneous use of other keratolytics so as not to increase the caustic action of the active substances.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLocalized irritation may occur if the product is applied to the skin surrounding the hyperkeratotic formation. Normally irritation should be controlled by temporary suspension and application of the product only to the affected area when treatment is resumed.\u003c\/p\u003e","brand":"Savoma","offers":[{"title":"Default Title","offer_id":51730204754247,"sku":"034603011","price":11.5,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/savoma-verunec-15-g-15-g-100-g-10-g-collodio-farmacia-dottor-tili-1254215768.jpg?v=1786736413"},{"product_id":"fitostimoline-15-10-garze-impregnate-crema","title":"Fitostimoline 15% 10 gauzes impregnated with cream","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eFITOSTIMOLINES 15% Cream and FITOSTIMOLINES 15% Impregnated gauzes\u003c\/b\u003e: treatment of ulcers and bedsores\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance to any of the excipients.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use, especially if prolonged, of all products for topical use can give rise to sensitization phenomena. If this occurs, treatment should be suspended and appropriate therapy instituted, if necessary. The same applies in the case of the development of insensitive germs. \u003cb\u003eImportant information about some excipients\u003c\/b\u003e \u003cb\u003ePhytostimolines 15% Cream \u003c\/b\u003econtains cetyl and stearyl alcohol: they may cause localized skin reactions (e.g. contact dermatitis).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known interactions or incompatibilities.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo side clinical manifestations or unwanted secondary effects have been reported.\u003c\/p\u003e","brand":"Damor","offers":[{"title":"Default Title","offer_id":51730204787015,"sku":"009115039","price":19.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/farmaceutici-damor-spa-fitostimoline-15-10-garze-impregnate-crema-farmacia-dottor-tili-1213791393.jpg?v=1767139210"},{"product_id":"benzac-gel-10-40-g-gel","title":"Benzac Gel 10% 40g gel","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSkin disinfection. It also has antiseptic activity against P. acnes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBenzac is for external use only. The use, especially if prolonged, of products for skin use can give rise to sensitization phenomena; in this case, stop treatment and consult your doctor to institute suitable therapy. Probably, at the first application you may feel a slight burning sensation and, within a few days, slight redness and peeling of the skin may occur. During the first weeks of treatment, a sudden increase in desquamation occurs in most patients. This is not dangerous and normally subsides within a day or two if treatment is temporarily stopped. Patients should be directed to use the drug less frequently, to temporarily discontinue or discontinue use, if severe irritation occurs. Benzoyl peroxide may cause swelling and blistering of the skin; if any of these symptoms occur, the medicine should be stopped. Avoid contact with eyes, mouth, corners of the nose and other mucous membranes. If the medicine gets into the eye, wash with plenty of water. Caution should be used when applying the medicine to the neck and other sensitive areas. The oxidizing action of the gel can discolor dyed hair and colored clothing. Do not apply to abraded or irritated skin. Avoid exposure to the sun and ultraviolet rays while applying benzoyl peroxide. \u003cu\u003ePediatric population\u003c\/u\u003e: No efficacy and safety data are available in children under 12 years of age. \u003cb\u003eBenzac 5% gel and Benzac 10% gel contain propylene glycol\u003c\/b\u003e Benzac 5% gel and Benzac 10% gel contain 4% propylene glycol, corresponding to 40 mg for each gram of gel.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid the simultaneous use of strong detergents, alcoholic products, anti-acne skin preparations and medicines used in the treatment of acne containing substances that can increase the effect \u003ci\u003epeeling,\u003c\/i\u003e irritants or that cause skin dryness, such as those based on tretinoin, resorcinol, salicylic acid and sulphides, medicated cosmetics.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe adverse reactions resulting from clinical studies are all related to skin disorders. They are reversible if treatment is reduced in frequency or stopped. The frequency of adverse reactions is divided into the following categories: Very common (≥1\/10); Common (≥1\/100, \u003c1\/10); Uncommon (≥1\/1,000, \u003c1\/100); Rare (≥1\/10,000, \u003c1\/1,000); Very rare (\u003c1\/10,000); Not known (frequency cannot be estimated from the available data). Adverse reactions are shown in the table below:\u003c\/p\u003e\n\u003cp\u003ePathologies of the skin and subcutaneous tissue\u003c\/p\u003e\n\u003cp\u003eVery common: erythema, skin exfoliation (scaling), burning sensation of the skin, dry skin\u003c\/p\u003e\n\u003cp\u003eCommon: Skin irritation (irritant contact dermatitis), pruritus, skin pain (pain, stinging)\u003c\/p\u003e\n\u003cp\u003eUncommon: allergic contact dermatitis\u003c\/p\u003e\n\u003cp\u003eCases of facial swelling and allergic reactions, including application site hypersensitivity and anaphylaxis, have been reported (frequency not known) from post-marketing pharmacovigilance data. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e","brand":"Galderma","offers":[{"title":"Default Title","offer_id":51730204983623,"sku":"032143012","price":24.61,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/galderma-italia-spa-benzac-gel-10-40-g-gel-farmacia-dottor-tili-1213791388.jpg?v=1767139359"},{"product_id":"trans-ver-sal-13-5-mg-12-mm-20-cerotti-transdermici-garzette-e-limetta","title":"Trans - Ver - Sal 13.5 mg\/12 mm 20 transdermal patches + egrets and lime","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor the treatment of common warts, calluses and calluses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. The product should not be used in case of diabetes or circulatory failure. Like all products with a high salicylic acid content, it should not be applied to the face, anogenital area and mucous membranes. The transdermal patch should not be applied to nevi, seborrheic warts and warts.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use, especially prolonged, of products for topical use can give rise to sensitization phenomena, in which case interrupt the treatment and institute a suitable therapy. Do not use for prolonged treatments, after a short period of treatment without appreciable results, consult your doctor. Avoid application on healthy skin surrounding the affected area. Keep out of reach of children. Avoid contact with eyes and mucous membranes. Do not use the product on irritated, infected or red skin. Do not ingest. In case of accidental ingestion, consult a doctor immediately. The product must not be used to prevent the formation of warts.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid the simultaneous use of other keratolytics so as not to increase the caustic action of the active substance.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn some cases, intolerance (burning or irritation) may occur, however without consequences and which does not require modification of the treatment.\u003c\/p\u003e","brand":"Difa Cooper","offers":[{"title":"Default Title","offer_id":51730205049159,"sku":"034674022","price":22.04,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/difa-cooper-spa-trans-ver-sal-13-5-mg-12-mm-20-cerotti-transdermici-garzette-e-limetta-farmacia-dottor-tili-1213791386.jpg?v=1767139426"},{"product_id":"trans-ver-sal-3-75-mg-6-mm-20-cerotti-transdermici-garzette-e-limetta","title":"Trans - Ver - Sal 3.75 mg\/6 mm 20 transdermal patches + egrets and lime","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor the treatment of common warts, calluses and calluses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. The product should not be used in case of diabetes or circulatory failure. Like all products with a high salicylic acid content, it should not be applied to the face, anogenital area and mucous membranes. The transdermal patch should not be applied to nevi, seborrheic warts and warts.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use, especially prolonged, of products for topical use can give rise to sensitization phenomena, in which case interrupt the treatment and institute a suitable therapy. Do not use for prolonged treatments, after a short period of treatment without appreciable results, consult your doctor. Avoid application on healthy skin surrounding the affected area. Keep out of reach of children. Avoid contact with eyes and mucous membranes. Do not use the product on irritated, infected or red skin. Do not ingest. In case of accidental ingestion, consult a doctor immediately. The product must not be used to prevent the formation of warts.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid the simultaneous use of other keratolytics so as not to increase the caustic action of the active substance.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn some cases, intolerance (burning or irritation) may occur, however without consequences and which does not require modification of the treatment.\u003c\/p\u003e","brand":"Difa Cooper","offers":[{"title":"Default Title","offer_id":51730205114695,"sku":"034674010","price":22.04,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/difa-cooper-spa-trans-ver-sal-3-75-mg-6-mm-20-cerotti-transdermici-garzette-e-limetta-farmacia-dottor-tili-1213791384.jpg?v=1767139390"},{"product_id":"benzac-gel-5-40-g-gel","title":"Benzac Gel 5% 40g gel","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSkin disinfection. It also has antiseptic activity against P. acnes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBenzac is for external use only. The use, especially if prolonged, of products for skin use can give rise to sensitization phenomena; in this case, stop treatment and consult your doctor to institute suitable therapy. Probably, at the first application you may feel a slight burning sensation and, within a few days, slight redness and peeling of the skin may occur. During the first weeks of treatment, a sudden increase in desquamation occurs in most patients. This is not dangerous and normally subsides within a day or two if treatment is temporarily stopped. Patients should be directed to use the drug less frequently, to temporarily discontinue or discontinue use, if severe irritation occurs. Benzoyl peroxide may cause swelling and blistering of the skin; if any of these symptoms occur, the medicine should be stopped. Avoid contact with eyes, mouth, corners of the nose and other mucous membranes. If the medicine gets into the eye, wash with plenty of water. Caution should be used when applying the medicine to the neck and other sensitive areas. The oxidizing action of the gel can discolor dyed hair and colored clothing. Do not apply to abraded or irritated skin. Avoid exposure to the sun and ultraviolet rays while applying benzoyl peroxide. \u003cu\u003ePediatric population\u003c\/u\u003e: No efficacy and safety data are available in children under 12 years of age. \u003cb\u003eBenzac 5% gel and Benzac 10% gel contain propylene glycol\u003c\/b\u003e Benzac 5% gel and Benzac 10% gel contain 4% propylene glycol, corresponding to 40 mg for each gram of gel.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid the simultaneous use of strong detergents, alcoholic products, anti-acne skin preparations and medicines used in the treatment of acne containing substances that can increase the effect \u003ci\u003epeeling,\u003c\/i\u003e irritants or that cause skin dryness, such as those based on tretinoin, resorcinol, salicylic acid and sulphides, medicated cosmetics.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe adverse reactions resulting from clinical studies are all related to skin disorders. They are reversible if treatment is reduced in frequency or stopped. The frequency of adverse reactions is divided into the following categories: Very common (≥1\/10); Common (≥1\/100, \u003c1\/10); Uncommon (≥1\/1,000, \u003c1\/100); Rare (≥1\/10,000, \u003c1\/1,000); Very rare (\u003c1\/10,000); Not known (frequency cannot be estimated from the available data). Adverse reactions are shown in the table below:\u003c\/p\u003e\n\u003cp\u003ePathologies of the skin and subcutaneous tissue\u003c\/p\u003e\n\u003cp\u003eVery common: erythema, skin exfoliation (scaling), burning sensation of the skin, dry skin\u003c\/p\u003e\n\u003cp\u003eCommon: Skin irritation (irritant contact dermatitis), pruritus, skin pain (pain, stinging)\u003c\/p\u003e\n\u003cp\u003eUncommon: allergic contact dermatitis\u003c\/p\u003e\n\u003cp\u003eCases of facial swelling and allergic reactions, including application site hypersensitivity and anaphylaxis, have been reported (frequency not known) from post-marketing pharmacovigilance data. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e","brand":"Galderma","offers":[{"title":"Default Title","offer_id":51730205344071,"sku":"032143024","price":23.66,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/galderma-italia-spa-benzac-gel-5-40-g-gel-farmacia-dottor-tili-1213791382.jpg?v=1767139472"},{"product_id":"connettivina-plus-0-2-1-25-g-crema","title":"Connettivina Plus 0.2% + 1% 25 g cream","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLocal treatment of mild wounds. Local treatment of 1st and 2nd degree burns\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances and other closely chemically related substances or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCONNETTIVINA PLUS must be used with caution in subjects who have shown previous allergies to sulphonamides and in the presence of hepatic or renal insufficiency.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLocal proteolytic enzymes, applied simultaneously with CONNETTIVINA PLUS, can be inactivated by the presence of silver ions. Do not use simultaneously with disinfectants containing quaternary ammonium salts as hyaluronic acid may precipitate in their presence.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAfter the application of CONNETTIVINA PLUS, local reactions (pain, burning, itching) may occur, even of an allergic nature. Since the systemic administration of sulphonamides can cause adverse reactions such as renal failure, toxic hepatitis, agranulocytosis, thrombocytopenia and leukopenia, it cannot be excluded that the local treatment of large parts of the body with CONNETTIVINA PLUS may give rise to side effects typical of sulphonamides administered systemically\u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e","brand":"Fidia","offers":[{"title":"Default Title","offer_id":51730206359879,"sku":"028440030","price":13.78,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/fidia-farmaceutici-spa-connettivina-plus-0-2-1-25-g-crema-farmacia-dottor-tili-1213791109.jpg?v=1767139991"},{"product_id":"sofargen-1-120-g-crema","title":"Sofargen 1% 120g cream","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProphylaxis and local antibacterial treatment of infections in case of 2nd and 3rd degree burns; local antibacterial treatment of varicose ulcers and infected bedsores and in general of dermatological conditions that are infected or susceptible to superinfections.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. Since sulphonamides may increase the risk of neonatal jaundice, Sofargen should not be used in women at the end of pregnancy, in premature babies and in newborns in the first months of life.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSofargen should be applied with caution in the presence of hepatic or renal insufficiency. The use of Sofargen may be risky in subjects with manifest glucose-6-phosphate dehydrogenase deficiency, as hemolytic phenomena may occur. Prolonged use of the product may give rise to sensitization phenomena. In this case it is necessary to interrupt the treatment and adopt suitable therapeutic measures. The same applies in case of superinfection by resistant microorganisms. In the treatment of burns of a large part of the body, serum concentrations of sulphonamide can reach therapeutic levels in adults. Therefore, in these patients it would be advisable to monitor these serum levels, renal function, the presence of any sulphonamide crystals in the urine and liver function, interrupting therapy if liver and\/or renal function is compromised. Furthermore, given that propylene glycol, present as an excipient in the composition, can cause hyperosmolality when the product is applied to large burn areas, serum osmolality must be periodically checked and, if necessary, the treatment must be interrupted.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLocal proteolytic enzymes, applied simultaneously with Sofargen, can be inactivated by the presence of silver ions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSome cases of transient leukopenia (0.4%), rare local disorders (pain and burning) and rare local allergic reactions (0.3%) have been reported. The classic side effects of systemically administered sulphonamides cannot be excluded when treating large parts of the body. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51730211373383,"sku":"025561073","price":26.41,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-sofargen-1-120-g-crema-farmacia-dottor-tili-1213791028.jpg?v=1767164747"},{"product_id":"sofargen-1-30-g-crema","title":"Sofargen 1% 30g cream","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProphylaxis and local antibacterial treatment of infections in case of 2nd and 3rd degree burns; local antibacterial treatment of varicose ulcers and infected bedsores and in general of dermatological conditions that are infected or susceptible to superinfections.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. Since sulphonamides may increase the risk of neonatal jaundice, Sofargen should not be used in women at the end of pregnancy, in premature babies and in newborns in the first months of life.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSofargen should be applied with caution in the presence of hepatic or renal insufficiency. The use of Sofargen may be risky in subjects with manifest glucose-6-phosphate dehydrogenase deficiency, as hemolytic phenomena may occur. Prolonged use of the product may give rise to sensitization phenomena. In this case it is necessary to interrupt the treatment and adopt suitable therapeutic measures. The same applies in case of superinfection by resistant microorganisms. In the treatment of burns of a large part of the body, serum concentrations of sulphonamide can reach therapeutic levels in adults. Therefore, in these patients it would be advisable to monitor these serum levels, renal function, the presence of any sulphonamide crystals in the urine and liver function, interrupting therapy if liver and\/or renal function is compromised. Furthermore, given that propylene glycol, present as an excipient in the composition, can cause hyperosmolality when the product is applied to large burn areas, serum osmolality must be periodically checked and, if necessary, the treatment must be interrupted.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLocal proteolytic enzymes, applied simultaneously with Sofargen, can be inactivated by the presence of silver ions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSome cases of transient leukopenia (0.4%), rare local disorders (pain and burning) and rare local allergic reactions (0.3%) have been reported. The classic side effects of systemically administered sulphonamides cannot be excluded when treating large parts of the body. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51730211701063,"sku":"025561010","price":14.23,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-sofargen-1-30-g-crema-farmacia-dottor-tili-1213791018.jpg?v=1767164908"},{"product_id":"acido-salicilico-marco-viti-10-30-g-unguento","title":"Salicylic acid Marco Viti 10% 30 g ointment","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e– Treatment of psoriasis, acne vulgaris, seborrhea in adults and children; – Removal of warts and calluses in adults and children; – Local treatment of some forms of eczema and ichthyosis in adults.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e– hypersensitivity to the active ingredient, to salicylates or to any of the excipients (patients hypersensitive to salicylates, such as acetylsalicylic acid, propylsalicylate, bromosacylic acid, zinc salicylate, may also be hypersensitive to salicylic acid); – children under the age of 2; – diabetes (see section 4.8); – peripheral vascular disease.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine must not be swallowed. Salicylic acid is irritating and could cause dermatitis (see section 4.8); When treating calluses and warts, it is necessary to protect the surrounding intact skin to minimize the absorption of the active ingredient. Salicylic acid must not be used for long periods of time, at high concentrations, on large areas of the body, or on damaged or inflamed skin, as excessive absorption of the active ingredient can cause systemic salicylate poisoning (see section 4.9) mainly in children, which can be fatal. Avoid contact with mouth, eyes, genitals and other mucous membranes. Use with caution in children as experience on the use of salicylic acid in this population is limited. It is possible to observe an improvement in the treated skin after 6 weeks of therapy or after 12 weeks in the case of removal of a wart.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSalicylic acid may interact with the following medicines: – Coumarin anticoagulants (acenocoumarol, dicoumarol, phenprocumon and warfarin) and 1,3-idandione derivatives (anisindione, phenidione), as salicylic acid can inhibit platelet aggregation and displace them from their binding site with plasma proteins, thus causing an increased risk of bleeding. – Inhibitors of coagulation-activated factor – Glyburide, since, due to an unknown mechanism, excessive hypoglycemia could occur. – Probenecid, as salicylic acid can cause the reversal of the uricosuric effects of this drug. – Acetazolamide, as you may experience an increase in side effects of salicylate. – Chickenpox vaccine, as salicylic acid may cause an increased risk of developing Reye's syndrome. Furthermore, salicylic acid should not be used at the same time as tamarind (tropical tree belonging to the \u003ci\u003eFabaceae\u003c\/i\u003e) and Salvia miltiorrhiza or Tan–Shen (plant of the \u003ci\u003eLabiateae\u003c\/i\u003e), as there could be a rapid increase in plasma levels of salicylate with consequent increase in toxicity.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of salicylic acid, organized according to the MedDRA systemic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eMetabolism and nutrition disorders\u003c\/i\u003e Hypoglycemia. \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e Irritations, dermatitis, burning, itching, erythema, peeling of the skin, scars on the face.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51730211766599,"sku":"030354031","price":5.77,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-acido-salicilico-marco-viti-10-30-g-unguento-farmacia-dottor-tili-1213791017.jpg?v=1767164889"},{"product_id":"ictammolo-marco-viti-10-50-g-unguento","title":"Ictammol Marco Viti 10% 50 g ointment","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eInflammations and small skin infections. Furunculosis (pimples), abscesses and superficial ulcerations of the skin. Inflammation of the sweat glands (hidradenitis).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS AND PRECAUTIONS FOR USE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not apply near the eyes and on the mucous membranes. Avoid exposure to the sun and UVA rays after application. The use, especially if prolonged, of medicines for local use can give rise to irritation or sensitization phenomena. If this occurs, discontinue treatment.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo specific interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of Ictammol, organized according to the MedDRA system organ classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e Dermatitis, burning, skin irritation, hypersensitivity reactions\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51730213536071,"sku":"030338026","price":6.05,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-ictammolo-marco-viti-10-50-g-unguento-farmacia-dottor-tili-1213790999.jpg?v=1767156009"}],"url":"https:\/\/www.dottortili.com\/en\/collections\/medicines-for-infections-and-skin-lesions.oembed?page=2","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}